PM534 Administered Intravenously to Patients With Advanced Solid Tumors

Clinical trial NCT05835609 · RECRUITING

Trial details

NCT number: NCT05835609
Sponsor: PharmaMar
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Advanced Solid Tumors

Start date: 2022-12-23
Primary completion: 2026-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.